Xilio Therapeutics CEO René Russo's 2021 pay jumps 118% to $5.5M
Xilio Therapeutics reports 2021 executive compensation
By ExecPay News
Published: April 26, 2022
Xilio Therapeutics reported fiscal year 2021 executive compensation information on April 26, 2022.
In 2021, three executives at Xilio Therapeutics received on average a compensation package of $3.6M, a 108% increase compared to previous year.
Average pay of disclosed executives at Xilio Therapeutics
René Russo, Chief Executive Officer, received $5.5M in total, which increased by 118% compared to 2020. 84% of Russo's compensation, or $4.6M, was in option awards. Russo also received $380K in non-equity incentive plan, $485K in salary, as well as $9.3K in other compensation.
Martin Huber, Chief Medical Officer, received a compensation package of $3.5M, which increased by 259% compared to previous year. 79% of the compensation package, or $2.7M, was in option awards.
Salvatore Giovine, Chief Financial Officer, earned $1.9M in 2021.
Related executives
You may also like
Source: SEC filing on April 26, 2022.